Recommendations for publishing case studies of cell transplantation for spinal cord injury

Neurorehabilitation and Neural Repair

Volumn 24, Issue 8, 2010, Pages 687-691

  Dobkin, Bruce H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autologous cell transplantation; clinical trials; OEC transplantation; spinal cord injury rehabilitation; stem cell transplantation

Indexed keywords

BIOLOGICAL ACTIVITY; CASE STUDY; FETUS (ANATOMY); HEMATOPOIETIC STEM CELL; HUMAN; MOTOR PERFORMANCE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLFACTORY ENSHEATHING CELL; PUBLICATION; REHABILITATION RESEARCH; REVIEW; SENSORIMOTOR FUNCTION; SPINAL CORD INJURY;

BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CELL TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; HUMANS; JOURNALISM, MEDICAL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE REGENERATION; OLFACTORY BULB; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STROMAL CELLS; TREATMENT OUTCOME;

EID: 77957740359     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968310377508     Document Type: Review

References (26)

1. Verma P., Garcia-Alias G., Fawcett JW Spinal cord repair: bridging the divide. Neurorehabil Neural Repair. 2008 ; 22: 429-437.
2. Dobkin BH Progressive staging of pilot studies to improve phase III trials for motor interventions. Neurorehabil Neural Repair. 2009 ; 23: 197-206.
3. Lima C., Escada P., Pratas-Vital J., et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2010 ; 24: 10-22.
4. Nirmeen A. Kishk, Hala Gabr, Sherif Hamdy, Lamiaa Afifi, Noha T. Abokrysha, Hayam Mahmoud, Ahmed Wafaie, Dalia Bilal. Case control series of intrathecal autologus bone marrow mesenchymal stem cells for chronic spinal cord injury. Neurorehabil Neural Repair. 2010 ; 24: 702-708.
5. Hyun I., Lindvall O., Ahrlund-Richter L., et al. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell. 2008 ; 3: 607-609.
6. Lammertse D., Tuszynski MH, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: clinical trial design. Spinal Cord. 2007 ; 45: 232-242.
7. Moher D., Hopewell S., Schulz K., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 ; 340: c869.
8. Fawcett JW, Curt A., Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 2007 ; 45: 190-205.
9. Mackay-Sim A., Feron F., Cochrane J., et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: 3-year clinical trial. Brain. 2008 ; 131: 2376-2386.
10. Thompson FJ, Reier PJ, Uthman, et al. Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia. J Neurotrauma. 2001 ; 18: 931-945.
11. Huang H., Chen L., Wang H., et al. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl). 2003 ; 116: 1488-1491.
12. Huang H., Wang H., Chen L., et al. Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 ; 20: 434-438.
13. Dobkin BH, Curt A., Guest J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair. 2006 ; 20: 5-13.
14. Lima C., Pratas-Vital J., Escada P., Hasse-Ferreira A., Capucho C., Peduzzi JD Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. Spinal Cord Med. 2006 ; 29: 191-203 ; discussion 204-206.
15. Chhabra S., Lima C., Sachdeva S., et al. Autologous olfactory mucosal transplant in chronic spinal cord injury: an Indian pilot study. Spinal Cord. 2009 ; 47: 887-895.
16. Dobkin BH What matters in cellular transplantation for spinal cord injury: the cells, the rehabilitation or the best mix? Neurorehabil Neural Repair. 2010 ; 24: 7-9.
17. Levin MF, Kleim JA, Wolf SL What do motor recovery and compensation mean in patients following stroke ? Neurorehabil Neural Repair. 2009 ; 23: 313-319.
18. Wernig A., de Carvalho M., Lopes A., Lima C. Olfactory ensheathing cells for human spinal cord injury [letter to the editor]. Neurorehabil Neural Repair. 2010 ; 24: 770-773.
19. Nadeau S., Jacquemin G., Fournier C., Lamarre Y., Rossignol S. Spontaneous motor rhythms of the back and legs in a patient with a complete spinal cord transection. Neurorehabil Neural Repair. 2010 ; 24: 377-383.
20. Scivoletto G., Ivanenko Y., Morganti B., et al. Plasticity of spinal centers in spinal cord injury patients: new concepts for gait evaluation and training. Neurorehabil Neural Repair. 2007 ; 21: 358-365.
21. Dobkin B., Barbeau H., Deforge D., et al. The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial. Neurorehabil Neural Repair. 2007 ; 21: 25-35.
22. Shichinohe H., Kuroda S., Tsuji S., et al. Bone marrow stromal cells promote neurite extension in organotypic spinal cord slice: significance for cell transplantation therapy. Neurorehabil Neural Repair. 2008 ; 22: 447-457.
23. Himes BT, Neuhuber B., Coleman C., et al. Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord. Neurorehabil Neural Repair. 2006 ; 20: 278-296.
24. Geffner LF, Santacruz P., Izurieta M., et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008 ; 17: 1277-1293.
25. Yoon S., Shim Y., Park Y., et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor (GM-CSF): phase I/II clinical trial. Stem Cells. 2007 ; 25: 2066-2073.
26. Nelson B. Stem cell researchers face down stem cell tourism [published online ahead of print June 5, 2008]. Nature Rep Stem Cells. doi:10.1038/ stemcells.2008.89.